A prospective, randomized clinical trial of cyclosporine reduction in stable patients greater than 12 months after renal transplantation

University of Alabama at Birmingham, Birmingham, Alabama, United States
Transplantation (Impact Factor: 3.78). 06/2003; 75(9):1501-5. DOI: 10.1097/01.TP.0000061606.64917.BE
Source: PubMed

ABSTRACT For stable kidney-transplant recipients receiving triple drug therapy with cyclosporine (CsA), prednisone, and mycophenolate mofetil (MMF), it remains unclear what is the optimal dose of CsA beyond the first 6 to 12 months after transplantation. Complete CsA withdrawal has been associated with a significant incidence of acute rejection and, in some studies, chronic rejection as well.
We performed an open, prospectively randomized, controlled clinical trial to determine whether CsA could be safely reduced by 50%. At 1 year or more posttransplant, 64 patients were randomized to either continue their stable-maintenance CsA dose (control group, n=32) or to lower their CsA dose by 50% over a 2 month period (CsA reduction group, n=32). All patients had stable renal-allograft function at the time of enrollment.
Within 6 months of randomization, no episode of acute rejection or graft loss occurred in either group. Patients in the CsA reduction group had a slight but significant increase in their glomerular filtration rate and a trend towards lower serum creatinine. There was also a significant decrease in mean systolic blood pressure, triglycerides, and serum uric acid levels in the CsA reduction group. No significant changes in any of these parameters were observed in the control group.
This study suggests that a strategy consisting of a 50% CsA reduction is safe and is not associated with the increased risk of acute rejection observed in CsA withdrawal studies. It also has the potential to improve short-term allograft function and appears to reduce cardiovascular risk factors such as hypertension and hyperlipidemia.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Surveys were conducted among family business owners in the tourism and hospitality industry in two resort areas (one in Canada and one in Denmark) with a view to identifying growth and profit-oriented entrepreneurs. Analysis of owners’ attitudes and goals reveals the predominance of lifestyle and autonomy orientations, but also profiles those who are more profit and growth oriented. This small sub-group differs somewhat in the two resorts—in both cases profit and growth orientation is significantly higher among those who purchased their business, particularly accommodation establishments and restaurants. Bed and breakfast and arts and craft businesses are clearly associated with lifestyle and autonomy. Theoretical, management and policy implications are discussed.
    International Journal of Hospitality Management 06/2005; DOI:10.1016/j.ijhm.2004.06.007 · 1.77 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Immunosuppressive therapy with calcineurin inhibitors (CNI) must be continued during the weeks following transplant to avoid acute rejection. Over the long-term, however, nephrotoxicity and morbidity induced by CNIs have a negative impact on patient and transplant survival. Therefore, for any organ, it is crucial to free patients from the nephrotoxicity associated with CNIs without risking under-immunosuppression and while maintaining good overall tolerance. For kidney transplants, minimization of CNI use in association with mycophenolate seems to be relatively safe and allows for improved kidney function without an added risk of rejection. The strategy of making a complete switch from CNIs to proliferation signal inhibitors (PSI) also seems to be promising. In patients with chronic allotransplant dysfunction, reduction of CNI doses by 30 to 50% in association with MPA seems to be safe and effective and replacement of CNIs with PSIs is pertinent, though limited by their effect on proteinuria. For liver transplants, late and minimal introduction of CNIs under induction seems to be safe and effective for the preservation of kidney function, especially when precarious. For heart transplants, preliminary studies conducted on a small number of patients suggest that delayed introduction of CNIs at minimal doses and late elimination of the therapy are safe after transplant.
    Néphrologie & Thérapeutique 12/2009; 5. DOI:10.1016/S1769-7255(09)73428-5 · 0.55 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The paper's purpose is to convey a progressive transcendental leadership model that aims to improve hospitality practices. It defines the concept of leadership, explores the attributes of multistream leadership behaviour, and analyzes recent leadership theories. The main consequence of the paper is that the paradigm presented provides theorists and practitioners opportunities for future research and industry application. Executives who have the power to effect change could assimilate the information in the article.
    International Journal of Hospitality Management 09/2011; 30(3):708-713. DOI:10.1016/j.ijhm.2010.12.005 · 1.77 Impact Factor